Ghost Tree Capital as of June 30, 2016
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 55 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 11.6 | $40M | 350k | 114.98 | |
| SPDR S&P Biotech (XBI) | 6.2 | $22M | 400k | 54.08 | |
| Spdr S&p 500 Etf (SPY) | 6.0 | $21M | 100k | 209.48 | |
| Boston Scientific Corporation (BSX) | 4.6 | $16M | 675k | 23.37 | |
| Clovis Oncology | 3.8 | $13M | 950k | 13.72 | |
| Gw Pharmaceuticals Plc ads | 3.4 | $12M | 130k | 91.57 | |
| Sarepta Therapeutics (SRPT) | 3.3 | $11M | 600k | 19.07 | |
| Ophthotech | 3.2 | $11M | 215k | 51.03 | |
| Alexion Pharmaceuticals | 3.0 | $11M | 90k | 116.76 | |
| NuVasive | 2.6 | $9.0M | 150k | 59.72 | |
| Medtronic (MDT) | 2.5 | $8.7M | 100k | 86.77 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $8.6M | 110k | 77.80 | |
| Edwards Lifesciences (EW) | 2.5 | $8.5M | 85k | 99.73 | |
| Tesaro | 2.4 | $8.4M | 100k | 84.06 | |
| CONMED Corporation (CNMD) | 2.4 | $8.4M | 175k | 47.73 | |
| Acorda Therapeutics | 2.4 | $8.3M | 325k | 25.50 | |
| Horizon Pharma | 2.1 | $7.4M | 450k | 16.47 | |
| Bluebird Bio (BLUE) | 2.1 | $7.4M | 170k | 43.29 | |
| Axovant Sciences | 2.1 | $7.4M | 575k | 12.84 | |
| Biogen Idec (BIIB) | 2.1 | $7.3M | 30k | 241.83 | |
| Spectranetics Corporation | 2.0 | $7.0M | 375k | 18.71 | |
| Intercept Pharmaceuticals In | 2.0 | $6.8M | 48k | 142.68 | |
| Nevro (NVRO) | 1.7 | $5.9M | 80k | 73.76 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $5.7M | 125k | 45.45 | |
| Lion Biotechnologies | 1.6 | $5.7M | 700k | 8.10 | |
| K2m Group Holdings | 1.6 | $5.4M | 350k | 15.52 | |
| Genomic Health | 1.5 | $5.2M | 200k | 25.90 | |
| Endologix | 1.4 | $5.0M | 400k | 12.46 | |
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $4.8M | 1.7M | 2.84 | |
| Intra Cellular Therapies (ITCI) | 1.4 | $4.7M | 120k | 38.82 | |
| Sage Therapeutics (SAGE) | 1.3 | $4.5M | 150k | 30.13 | |
| Wright Medical Group Nv | 1.2 | $4.3M | 250k | 17.37 | |
| Pacira Pharmaceuticals (PCRX) | 1.2 | $4.0M | 120k | 33.73 | |
| Flamel Technologies | 1.1 | $3.8M | 350k | 10.74 | |
| Raptor Pharmaceutical | 0.9 | $3.2M | 600k | 5.37 | |
| Nanostring Technologies (NSTGQ) | 0.9 | $3.2M | 250k | 12.60 | |
| Immunomedics | 0.8 | $2.8M | 1.2M | 2.32 | |
| Celgene Corporation | 0.7 | $2.5M | 25k | 98.64 | |
| Entellus Medical Cm | 0.6 | $2.2M | 120k | 18.27 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $1.8M | 800k | 2.23 | |
| Veracyte (VCYT) | 0.5 | $1.7M | 342k | 5.03 | |
| D Fluidigm Corp Del (LAB) | 0.4 | $1.4M | 150k | 9.03 | |
| Alcobra | 0.4 | $1.3M | 300k | 4.49 | |
| Ascendis Pharma A S (ASND) | 0.4 | $1.3M | 100k | 13.27 | |
| Gilead Sciences (GILD) | 0.4 | $1.3M | 15k | 83.40 | |
| Tandem Diabetes Care | 0.3 | $1.1M | 150k | 7.54 | |
| Corbus Pharmaceuticals Hldgs | 0.3 | $897k | 300k | 2.99 | |
| Radius Health | 0.2 | $735k | 20k | 36.75 | |
| Medivation | 0.2 | $633k | 11k | 60.29 | |
| Akari Therapeutics | 0.2 | $629k | 47k | 13.49 | |
| Heron Therapeutics (HRTX) | 0.1 | $451k | 25k | 18.04 | |
| Mirati Therapeutics | 0.1 | $410k | 75k | 5.47 | |
| Aeglea Biotherapeutics | 0.1 | $243k | 50k | 4.86 | |
| Synergy Pharmaceuticals | 0.0 | $84k | 22k | 3.82 | |
| Ocera Therapeutics | 0.0 | $68k | 36k | 1.90 |
